2022 Annual Meeting | C98 - Epilepsy: Surgery and Neuromodulation
Program Materials Program Evaluations
| 01:00 PM - 01:05 PM PDT | Introduction |
Introduction
Carol M. Ulloa, MD, FAES, FAAN |
| 01:00 PM - 01:00 PM PDT | Speaker |
Walk-in Slides
Carol M. Ulloa, MD, FAES, FAAN |
| 01:05 PM - 01:35 PM PDT | Speaker |
Using Minimally Invasive Epilepsy Procedures to Reframe Epilepsy Surgery Consideration
Patrick Landazuri, MD, FAAN |
| 01:35 PM - 02:05 PM PDT | Speaker |
Neuromodulation in Epilepsy
Vikram Rao, MD |
| 02:05 PM - 03:00 PM PDT | Speaker |
Cases with Panel Discussion
Carol M. Ulloa, MD, FAES, FAAN, Patrick Landazuri, MD, FAAN, Vikram Rao, MD, Barbara C. Jobst, MD, PhD, FAAN |
| Barbara C. Jobst, MD, PhD, FAAN | Dr. Jobst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Jobst has received research support from Neuropace, Inc.. The institution of Dr. Jobst has received research support from NIH. The institution of Dr. Jobst has received research support from CDC. |
| Vikram Rao, MD | Dr. Rao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precisis GmbH. Dr. Rao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for iVEAcare. Dr. Rao has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Echo Neurotechnologies. Dr. Rao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace, Inc.. Dr. Rao has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Rao has or had stock in Novela Neurotechnologies.Dr. Rao has or had stock in EnlitenAI.Dr. Rao has or had stock in Doximity, Inc.Dr. Rao has or had stock in Theta Neurotech.Dr. Rao has or had stock in Encephalogix.Dr. Rao has or had stock in Echo Neurotechnologies. |
| Carol M. Ulloa, MD, FAES, FAAN | The institution of Dr. Ulloa has received research support from medtronics. An immediate family member of Dr. Ulloa has received research support from NIH. |
| Patrick Landazuri, MD, FAAN | Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace. Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuropace. Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Federal Public Defender - District of Kansas. Dr. Landazuri has received publishing royalties from a publication relating to health care. |